Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder
Author(s) -
Simone C Oudshoorn,
Theodora C van Tilborg,
Marinus J.C. Eijkemans,
G. J. E. Oosterhuis,
Jaap Friederich,
Marcel H A van Hooff,
Evert J. P. van Santbrink,
Egbert A Brinkhuis,
J Smeenk,
Janet Kwee,
Corry H de Koning,
Henk Groen,
Cornelis B. Lambalk,
Ben W. Mol,
Frank J. Broekmans,
Helen L. Torrance,
Monique H. Mochtar,
Carolien Koks,
Ron J T van Golde,
Harold R Verhoeve,
Annemiek W. Nap,
Gabriëlle J Scheffer,
A Petra Manger,
Annemieke Hoek,
Bendictus C Schoot,
W. K. H. Kuchenbecker,
Kathrin Fleischer,
Jan Peter de Bruin,
Alexander V Sluijmer,
Arie Verhoeff,
Madelon van Wely,
Joop S.E. Laven
Publication year - 2017
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dex319
Subject(s) - ovarian hyperstimulation syndrome , live birth , medicine , antral follicle , polycystic ovary , randomized controlled trial , ovarian reserve , gynecology , pregnancy rate , obstetrics , pregnancy , in vitro fertilisation , infertility , ovary , biology , insulin resistance , genetics , insulin
Does a reduced FSH dose in women with a predicted hyper response, apparent from a high antral follicle count (AFC), who are scheduled for IVF/ICSI lead to a different outcome with respect to cumulative live birth rate and safety?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom